CLCGY (CLCGY) Stock Price & Analysis
CLCGY (CLCGY) fell 1.42% to USD 28.49 as of June 10, 2026 at 03:33 UTC, according to Nexqual real-time market data.
CLCGY last closed at USD 28.9; the session ranged USD 28.23–28.72 on volume of 157 shares. Market capitalization is $3.33B, with a 52-week range of USD 28.23–44.41 (PNK). Source: Nexqual, June 10, 2026 at 03:33 UTC.
Key Statistics (as of June 10, 2026 at 03:33 UTC)
| Price | USD 28.49 |
|---|---|
| Change | ▼ 1.42% (down) |
| Previous Close | USD 28.9 |
| Open | USD 28.7 |
| Day Range | USD 28.23 – 28.72 |
| 52-Week Range | USD 28.23 – 44.41 |
| Volume | 157 shares |
| Market Cap | $3.33B |
| Exchange | PNK |
Technical Analysis (CLCGY)
Nexqual's technical model rates CLCGY "SELL" based on 2 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:33 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 26.98 (oversold) |
| vs SMA50 | Below (USD 32.48) |
| MACD | -1.08 (negative) |
Analyst Ratings (CLCGY)
Wall Street analysts rate CLCGY "None", per Nexqual as of June 10, 2026 at 03:33 UTC.
| Consensus Rating | None |
|---|
Earnings (CLCGY)
Source: Nexqual, June 10, 2026 at 03:33 UTC.
Financials & Fundamentals (CLCGY)
| Total Revenue | $49.54B |
|---|---|
| Revenue Growth (YoY) | +7.40% |
| Gross Margin | +23.54% |
| Operating Margin | +9.06% |
| Profit Margin | +6.72% |
| ROE | +53.34% |
| Debt / Equity | 72.38 |
| Current Ratio | 1.05 |
| Total Cash | $1.24B |
| Total Debt | $4.41B |
| Free Cash Flow | $3.83B |
Source: Nexqual, June 10, 2026 at 03:33 UTC.
Financial Health Score (CLCGY)
Nexqual rates CLCGY's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 03:33 UTC.
| Growth | Solid — Revenue +5% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 24%, operating 9% |
| Balance Sheet | Solid — $1.24B cash vs $4.41B debt |
| Cash Flow | Solid — FCF $3.83B, 8% margin |
| Efficiency | Strong — ROE 53%, ROA 13.8% |
Ownership (CLCGY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.04% |
| Shares Outstanding | 116.93M |
| Float | 116.86M |
Source: Nexqual, June 10, 2026 at 03:33 UTC.
Leadership (CLCGY)
CLCGY is led by Bertina D. Engelbrecht B.Proc, LLM (age 62), CEO & Executive Director, per Nexqual as of June 10, 2026 at 03:33 UTC.
| CEO & Executive Director | Bertina D. Engelbrecht B.Proc, LLM (age 62) |
|---|---|
| CFO, Chief Support Services Officer & Director | Gordon D. Traill (age 54) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BDVSY | Bidvest Group Ltd. | USD 28.27 | ▲ 0.96% |
| MRPLY | Mr. Price Group Ltd. | USD 8.94 | ▲ 0% |
| SRGHY | Shoprite Holdings Ltd. | USD 17.46 | ▲ 1.57% |
| APNHY | Aspen Pharmacare Holdings plc | USD 9.03 | ▲ 1.8% |
| CHEOY | CochLear Ltd. | USD 36.24 | ▲ 3.81% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:33 UTC. This page is informational and not investment advice.